[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Alphatec Spine, Inc.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":94},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,40,61],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100579939","bone-mineral-density-precision-study-100579939",false,"NCT06830811","Bone Mineral Density Precision Study","Precision Assessment of Bone Mineral Density (BMD) Measurement With EOSedge™ - BMD Precision Study","Inclusion Criteria:\n\n1. Subjects indicated for full-spine or whole-body radiography via EOSedge 2E biplanar imaging (e.g., in the preoperative evaluation of spine and\u002For other orthopaedic conditions)\n2. Male or female subjects who are at least 20 years of age at the time of imaging acquisition\n3. Written informed consent obtained from the potential subject or the subject's legal representative and ability for the subject to comply with the requirements of the study\n\nExclusion Criteria:\n\n1. Subjects who have been administered contrast agents or radionuclides within 7 days prior to scheduled radiographic imaging (EOS and DXA)\n2. Subjects who are pregnant or wanting to become pregnant during the timeframe of study participation (due to risks associated with radiographic imaging)\n3. Subjects with a BMI ≥ 35 kg\u002Fm2\n4. Subjects known to have severe degenerative changes or fracture deformity in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck\u002Ftrochanter; note that unilateral femoral evaluation is acceptable), as defined by the Investigator's determination of the likelihood of reasonably assessing bone mineral density of those areas\n5. Subjects known to have implants, hardware, devices, or other foreign material in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck\u002Ftrochanter; note that unilateral femoral evaluation is acceptable)\n6. Subjects unable to attain correct position and\u002For remain motionless for the measurement (e.g., subjects unable to stand unassisted in the EOS unit, or to lie appropriately in the DXA scanner)\n7. Subjects known to have extra or missing lumbar vertebrae (i.e., more or fewer than 5 mobile lumbar segments)\n8. Subjects participating in another clinical study which may compromise this study's results or compliance with this study's procedures\n9. Subjects with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data","ALL","20 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two low-dose x-ray exams. The main question it aims to answer is:\n\nWhat is the precision measurement between the BMD assessments from 2 x-ray exams?",[26],"Indicated for EOSedge Imaging","RECRUITING","2025-02-12",{"date":30,"type":31},"2025-02-17","ACTUAL",{"date":33,"type":31},"2024-11-13",{"date":35,"type":20},"2025-03",{"name":37,"class":38},"Alphatec Spine, Inc.","INDUSTRY",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":21,"phases":50,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":59,"locationsCount":60},"100566736","bone-mineral-density-agreement-study-between-eosedge-versus-traditional-dxa-100566736","NCT06659055","Bone Mineral Density Agreement Study Between EOSedge™ Versus Traditional DXA","Bone Mineral Density Assessment Using Dual-energy Stereoradiography: Agreement Between BMD T-scores From EOSedge™ Versus Traditional DXA - BMD Agreement Study","Inclusion Criteria:\n\n1. Observational Arm:\n\n   o Subjects at clinical sites, indicated for full-spine or whole-body radiography via EOSedge 2E biplanar imaging (e.g., in the preoperative evaluation of spine and\u002For other orthopaedic conditions) as part of their routine medical care. Participants may already have completed their routine imagining, or may be scheduled to undergo it within 60 days of study enrollment.\n2. Interventional Arm:\n\n   o Volunteers at non-clinical sites, who meet the criteria to undergo non-diagnostic imaging, as part of a research study.\n3. Male or female subjects who are at least 20 years of age at the time of imaging acquisition\n4. Written informed consent obtained from the potential subject and ability for the subject to comply with the requirements of the study\n\nExclusion Criteria:\n\n1. Subjects who have been administered contrast agents or radionuclides within 7 days prior to scheduled radiographic imaging (EOS and DXA)\n2. Subjects who are pregnant or wanting to become pregnant during the timeframe of study participation (due to risks associated with radiographic imaging)\n3. Subjects with a BMI ≥ 35 kg\u002Fm2\n4. Subjects known to have severe degenerative changes or fracture deformity in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck\u002Ftrochanter; note that unilateral femoral evaluation is acceptable), as defined by the Investigator's determination of the likelihood of reasonably assessing bone mineral density of those areas\n5. Subjects known to have implants, hardware, devices, or other foreign material in the measurement area (i.e., lumbar spine L1-L4, bilateral femoral neck\u002Ftrochanter; note that unilateral femoral evaluation is acceptable)\n6. Subjects unable to attain correct position and\u002For remain motionless for the measurement (e.g., subjects unable to stand unassisted in the EOS unit, or to lie appropriately in the DXA scanner)\n7. Subjects known to have extra or missing lumbar vertebrae (i.e., more or fewer than 5 mobile lumbar segments)\n8. Subjects participating in another clinical study which may compromise this study's results or compliance with this study's procedures\n9. Subjects with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data",true,{"count":49,"type":20},214,[23],"The purpose of this research is to collect medical imaging data to allow for the comparison of bone mineral density measurements from two different types of low-dose x-ray exams, EOSedge and conventional DXA. The main question it aims to answer is:\n\nIs there agreement between the calculated T-scores between the 2 different types of x-ray exams?",[53,26],"Healthy",{"date":55,"type":31},"2025-02-14",{"date":57,"type":31},"2024-09-11",{"date":35,"type":20},{"name":37,"class":38},4,{"id":62,"slug":63,"hasResults":11,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":4,"eligibilityCriteria":67,"healthyVolunteers":11,"sex":16,"minAge":68,"maxAge":4,"enrollmentInfo":69,"targetDuration":4,"studyType":71,"phases":4,"briefSummary":72,"conditions":73,"keywords":79,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":39},"100489081","intraoperative-monitoring-for-the-lateral-lumbar-interbody-fusion-procedure-100489081","NCT05648474","Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure","Advanced Techniques in Intraoperative Monitoring for the Lateral Lumbar Interbody Fusion Procedure: a Utility Study","Inclusion Criteria:\n\n* At least 18 years of age at the time of planned surgery.\n* Indicated for 1- or 2-level instrumented LLIF surgery (in either prone or lateral decubitus positions), inclusive of the L4-5 disc space.\n* Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.\n\nExclusion Criteria:\n\n* Patients requiring surgical treatment at more than 2 lumbar levels.\n* Patients with peripheral neuropathy such as from diabetes or other conditions that might affect the reliability of intraoperative neuromonitoring.\n* Patients with prior history of partial\u002Ffull hip or knee joint replacement surgery (i.e., arthroplasty or resurfacing) on the leg targeted for saphenous monitoring and electrode placement.\n* Patients with presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.\n* Female patients who are pregnant or wanting to become pregnant during the timeframe of study participation.\n* Patients participating in another clinical study which may compromise this study's results or compliance with this study's procedures.","18 Years",{"count":70,"type":20},400,"OBSERVATIONAL","This study is designed to evaluate the clinical utility of a known intraoperative neuromonitoring modality (SSEP) using saphenous nerve as the site of stimulation to identify changes to the lumbar nerves which may be at risk during the lateral lumbar interbody fusion (LLIF) procedure.",[74,75,76,77,78],"Intervertebral Disc Degeneration","Stenosis, Spinal","Spondylolisthesis","Spinal Deformity","Spinal Instability",[80,81,82,83,84,85],"Spine","Surgery","Adult","Neuromonitoring","Electromyography","Somatosensory evoked potentials","2024-10-22",{"date":88,"type":31},"2024-10-24",{"date":90,"type":31},"2022-07-13",{"date":92,"type":20},"2025-12-31",{"name":37,"class":38},""]